Tenascin-C nucleic acid ligands
US7005260B1 · kind B1 · utility
3Cited by
12References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 28, 2000 |
| Grant date | Feb 28, 2006 |
| Priority date | — |
| Expiry date | Jan 28, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/158
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Methods are described for the identification and preparation of nucleic acid ligands to tenascin-C. Included in the invention are specific RNA ligands to tenascin-C identified by the SELEX method. Further included in the invention are methods for detecting the presence of a disease condition in a biological tissue in which tenascin-C is expressed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.